Cargando…

CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation

Detalles Bibliográficos
Autores principales: Xu, Qianwen, Xu, Hui, Xue, Lei, Wang, Min, Pan, Guiwang, Zhang, Xuhan, Song, Kaidi, Yao, Wen, Wan, Xiang, Tong, Juan, Liu, Huilan, Xu, Hanying, Liu, Xin, Zhu, Xiaoyu, Sun, Zimin, Yang, Lin, Wang, Xingbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850813/
https://www.ncbi.nlm.nih.gov/pubmed/33967196
http://dx.doi.org/10.1097/CM9.0000000000001491
_version_ 1784652681457958912
author Xu, Qianwen
Xu, Hui
Xue, Lei
Wang, Min
Pan, Guiwang
Zhang, Xuhan
Song, Kaidi
Yao, Wen
Wan, Xiang
Tong, Juan
Liu, Huilan
Xu, Hanying
Liu, Xin
Zhu, Xiaoyu
Sun, Zimin
Yang, Lin
Wang, Xingbing
author_facet Xu, Qianwen
Xu, Hui
Xue, Lei
Wang, Min
Pan, Guiwang
Zhang, Xuhan
Song, Kaidi
Yao, Wen
Wan, Xiang
Tong, Juan
Liu, Huilan
Xu, Hanying
Liu, Xin
Zhu, Xiaoyu
Sun, Zimin
Yang, Lin
Wang, Xingbing
author_sort Xu, Qianwen
collection PubMed
description
format Online
Article
Text
id pubmed-8850813
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88508132022-02-18 CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation Xu, Qianwen Xu, Hui Xue, Lei Wang, Min Pan, Guiwang Zhang, Xuhan Song, Kaidi Yao, Wen Wan, Xiang Tong, Juan Liu, Huilan Xu, Hanying Liu, Xin Zhu, Xiaoyu Sun, Zimin Yang, Lin Wang, Xingbing Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-01-05 2021-05-06 /pmc/articles/PMC8850813/ /pubmed/33967196 http://dx.doi.org/10.1097/CM9.0000000000001491 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Xu, Qianwen
Xu, Hui
Xue, Lei
Wang, Min
Pan, Guiwang
Zhang, Xuhan
Song, Kaidi
Yao, Wen
Wan, Xiang
Tong, Juan
Liu, Huilan
Xu, Hanying
Liu, Xin
Zhu, Xiaoyu
Sun, Zimin
Yang, Lin
Wang, Xingbing
CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
title CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
title_full CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
title_fullStr CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
title_full_unstemmed CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
title_short CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
title_sort cd19-targeted chimeric antigen receptor-modified t cells induce remission in patients with relapsed acute b lymphoblastic leukemia after umbilical cord blood transplantation
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850813/
https://www.ncbi.nlm.nih.gov/pubmed/33967196
http://dx.doi.org/10.1097/CM9.0000000000001491
work_keys_str_mv AT xuqianwen cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT xuhui cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT xuelei cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT wangmin cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT panguiwang cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT zhangxuhan cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT songkaidi cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT yaowen cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT wanxiang cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT tongjuan cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT liuhuilan cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT xuhanying cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT liuxin cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT zhuxiaoyu cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT sunzimin cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT yanglin cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation
AT wangxingbing cd19targetedchimericantigenreceptormodifiedtcellsinduceremissioninpatientswithrelapsedacuteblymphoblasticleukemiaafterumbilicalcordbloodtransplantation